ERD

Periodic Reporting for period 4 - CARAMBA (SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherap...

Project: CARAMBA

Updated at: 28-02-2024

Show more information

Project acronym CARAMBA

Publication on the use of patient reported outcomes in CART clinical trials

Project: CARAMBA

Updated at: 28-02-2024

Show more information

Project acronym CARAMBA

Final dissemination activity on project results

Project: CARAMBA

Updated at: 28-02-2024

Show more information

Project acronym CARAMBA

Novel targets and technologies for CAR-T cells in multiple myeloma and acute myeloid leukemia

Project: CARAMBA

Updated at: 31-10-2023

Show more information

Project acronym CARAMBA

Genomic Analyses of SLAMF7 CAR-T Cells Manufactured by Sleeping Beauty Transposon Gene Transfer for Immunotherapy of Mul...

Project: CARAMBA

Updated at: 31-10-2023

Show more information

Project acronym CARAMBA

Antibody‐Based CAR T Cells Produced by Lentiviral Transduction

Project: CARAMBA

Updated at: 31-10-2023

Show more information

Project acronym CARAMBA

Launch of website and social media accounts

Project: CARAMBA

Updated at: 31-10-2023

Show more information

Project acronym CARAMBA

Regulatory workshop

Project: CARAMBA

Updated at: 31-10-2023

Show more information

Project acronym CARAMBA

CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to...

Project: CARAMBA

Updated at: 31-10-2023

Show more information

Project acronym CARAMBA

CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term re...

Project: CARAMBA

Updated at: 31-10-2023

Show more information

Project acronym CARAMBA

The era of in vivo T cell engineering

Project: CARAMBA

Updated at: 31-10-2023

Show more information

Project acronym CARAMBA

Latest Advances for the Sleeping Beauty Transposon System: 23 Years of Insomnia but Prettier than Ever

Project: CARAMBA

Updated at: 31-10-2023

Show more information

Project acronym CARAMBA

Non-viral therapeutic cell engineering with the Sleeping Beauty transposon system

Project: CARAMBA

Updated at: 31-10-2023

Show more information

Project acronym CARAMBA

CAR T-Cells in Multiple Myeloma: State of the Art and Future Directions

Project: CARAMBA

Updated at: 31-10-2023

Show more information

Project acronym CARAMBA

Report on stakeholder involvement after kick-off meeting

Project: CARAMBA

Updated at: 31-10-2023

Show more information

Project acronym CARAMBA

CRISISS: A Novel, Transcriptionally and Post-Translationally Inducible CRISPR/Cas9-Based Cellular Suicide Switch

Project: CARAMBA

Updated at: 31-10-2023

Show more information

Project acronym CARAMBA

All-trans retinoic acid works synergistically with the γ-secretase inhibitor crenigacestat to augment BCMA on multiple ...

Project: CARAMBA

Updated at: 31-10-2023

Show more information

Project acronym CARAMBA

Current Limitations and Perspectives of Chimeric Antigen Receptor-T-Cells in Acute Myeloid Leukemia

Project: CARAMBA

Updated at: 31-10-2023

Show more information

Project acronym CARAMBA

Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia

Project: CARAMBA

Updated at: 31-10-2023

Show more information

Project acronym CARAMBA

Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancie...

Project: CARAMBA

Updated at: 31-10-2023

Show more information

Project acronym CARAMBA

CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine rel...

Project: CARAMBA

Updated at: 31-10-2023

Show more information

Project acronym CARAMBA

CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome

Project: CARAMBA

Updated at: 31-10-2023

Show more information

Project acronym CARAMBA

Summer school for young investigators

Project: CARAMBA

Updated at: 31-10-2023

Show more information

Project acronym CARAMBA

Resources

Selected filters:

Periodic Reporting for period 4 - CARAMBA (SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherap...

Publication on the use of patient reported outcomes in CART clinical trials

Final dissemination activity on project results

Novel targets and technologies for CAR-T cells in multiple myeloma and acute myeloid leukemia

Genomic Analyses of SLAMF7 CAR-T Cells Manufactured by Sleeping Beauty Transposon Gene Transfer for Immunotherapy of Mul...

Antibody‐Based CAR T Cells Produced by Lentiviral Transduction

Launch of website and social media accounts

Regulatory workshop

CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to...

CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term re...

The era of in vivo T cell engineering

Latest Advances for the Sleeping Beauty Transposon System: 23 Years of Insomnia but Prettier than Ever

Non-viral therapeutic cell engineering with the Sleeping Beauty transposon system

CAR T-Cells in Multiple Myeloma: State of the Art and Future Directions

Report on stakeholder involvement after kick-off meeting

CRISISS: A Novel, Transcriptionally and Post-Translationally Inducible CRISPR/Cas9-Based Cellular Suicide Switch

All-trans retinoic acid works synergistically with the γ-secretase inhibitor crenigacestat to augment BCMA on multiple ...

Current Limitations and Perspectives of Chimeric Antigen Receptor-T-Cells in Acute Myeloid Leukemia

Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia

Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancie...

CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine rel...

CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome

Summer school for young investigators